Saudi drug authority assessing new batch of COVID-19 vaccines for approval

05/04/2021 Argaam

Logo of Saudi Food and Drug Authority

Saudi Food and Drug Authority (SFDA) announced that a new batch of COVID-19 vaccines was received and is currently being studied and assessed in order to be approved soon, Al-Arabiya website reported.

 

The drug authority approved in December 2020 the registration of the Pfizer-BioNTech COVID-19 vaccine in the Kingdom, followed by the AstraZeneca vaccine last February.

 

Meanwhile, the Ministry of Health latest data showed that a total of 5.03 million doses of COVID-19 vaccines had been administered so far in the Kingdom.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.